UroGen Pharma Says FDA Approves Plan For Rolling NDA Submission For UGN-102 From January 2024

RTTNews | Pred 695 dňami
Stocktwits
UroGen Pharma Says FDA Approves Plan For Rolling NDA Submission For UGN-102 From January 2024

(RTTNews) - Biotech company UroGen Pharma Ltd. (URGN) announced Tuesday that it has reached agreement with the U.S. Food and Drug Administration (FDA) on plans for submission of a New Drug Application (NDA) for UGN-102 (mitomycin) for intravesical solution.

The FDA indicated that the current clinical development plan for UGN-102, which includes evaluation of duration of complete response (CR) at 12 months from the pivotal ENVISION trial, will support submission of an NDA for the treatment of low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC).

The FDA also agreed that the UGN-102 NDA can utilize a rolling review, allowing for early submission of the Chemistry, Manufacturing and Controls (CMC) sections of the NDA, which is planned for January 2024.

If approved, UGN-102 has the potential to introduce a new non-surgical treatment paradigm for LG-IR-NMIBC, a subset of bladder cancer patients characterized by high recurrence rates and the need for multiple surgeries.

The UGN-102 clinical development plan centers around the Phase 3 ENVISION pivotal trial and is supported by robust clinical data from the ATLAS Phase 3 and OPTIMA Phase 2b trials.

Značky: URGN
Stocktwits
read more
UroGen Pharma Files Patent Infringement Lawsuit Against Teva Pharma

UroGen Pharma Files Patent Infringement Lawsuit Against Teva Pharma

Biotech company UroGen Pharma Ltd. (URGN) announced Wednesday that it has filed a lawsuit in the U.S. District Court for the District of Delaware against Teva Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc., and Teva Pharmaceutical Industries, Ltd. (TEVA), alleging infringement of U.S. Patent Numbers 9,040,074 and 9,950,069.
RTTNews | Pred 512 dňami
FTSE 100 Down 0.4% In Cautious Trade

FTSE 100 Down 0.4% In Cautious Trade

After a slightly positive start, U.K. stocks turned weak Thursday morning with investors treading cautiously amid a lack of triggers. Shares of financials and utilities companies are struggling a bit.
RTTNews | Pred 6 minútami
CAC Up Slightly; Pernod Ricard Rises On Earnings

CAC Up Slightly; Pernod Ricard Rises On Earnings

The French market is up slightly a little past noon on Thursday, supported by data showing an increase in new car registrations in Europe, and stronger-than-expected results and forecast from AI chip major Nvidia.
RTTNews | Pred 25 minútami
DAX Retreats After Firm Start, Down Marginally

DAX Retreats After Firm Start, Down Marginally

After opening on a strong note thanks to easing AI slowdown fears after Nvidia's impressive results, the German market retreated and slipped into negative territory on Thursday. Despite paring some early gains, auto stocks remain fairly well up in positive territory.
RTTNews | Pred 48 minútami
Sensex, Nifty Retreat On US Tariff Worries

Sensex, Nifty Retreat On US Tariff Worries

Indian shares fell sharply on Thursday as traders waited to see how New Delhi responds to pressure from Washington to stop buying Russian oil after the 50 percent tariffs levied by the U.S. on Indian goods came into effect on Wednesday.
RTTNews | Pred 1 h 9 min
Bank Of Korea Stands Pat On Rates, Lifts 2025 Growth Outlook

Bank Of Korea Stands Pat On Rates, Lifts 2025 Growth Outlook

The Bank of Korea left its interest rate unchanged on Thursday as economic growth improved moderately despite high uncertainty surrounding the outlook. The Monetary Policy Board decided to hold the Base Rate at 2.50 percent. The central bank had previously lowered the benchmark rate by a quarter-point each in May and February.
RTTNews | Pred 1 h 15 min
Nástroje
Ekonomický kalendár
Otváracie hodiny trhu
Úrokové sadzby
Kalendár sviatkov
Forexový trh
Forex Volatilita
Korelácia Forexu
Novinky na Forexe
Analýza forexu
COT Údaje
Likvidita
Forex kalkulačky
Forex Tepelná mapa
Tepelná mapa indikátorov
Komunita
Komunita
Systémy
Najpopulárnejšie systémy
Stratégie
Súťaže
Forexové grafy
Forexový sentiment
Indikátor Outlook
Recenzie
Brokeri
Proprietárne obchodné firmy
Služby VPS
Poskytovatelia signálu
Služby programovania EA
Partnerské programy
Služby brokera PAMM
Služby zľavového programu
Obchodné platformy
Odborní poradcovia
Kryptoburzy
Obchodné kurzy
Brokeri
Forex Spready
Ponuky Forex brokerov
Swapy Forex brokerov
Objem brokera Forexu
Propagačné akcie Forex Brokera
Tlačová Správa
Platforma
Miniaplikácie
Funkcie
API
RSS
Stock Portfolio
Affiliate Software
Rozšírené grafy
Podpora
Často kladené otázky
Pomoc
Kontaktuj nás
Nahlásiť chybu!
O
Blog
& copy; 2025 Myfxbook Ltd. Všetky práva vyhradené.
UPOZORNENIE NA VYSOKÉ RIZIKO: Obchodovanie s devízami prináša vysokú úroveň rizika, ktoré nemusí byť vhodné pre všetkých investorov. Páka vytvára ďalšie riziká a straty. Než sa rozhodnete obchodovať s devízami, dôkladne zvážte svoje investičné ciele, úroveň skúseností a toleranciu voči riziku. Môžete prísť o časť alebo všetky svoje počiatočné investície. Neinvestujte peniaze, ktoré si nemôžete dovoliť stratiť. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Všetky údaje a informácie sú poskytované „tak, ako sú“. iba na informačné účely a nie je určené na obchodné účely alebo rady. Výkonnosť v minulosti neznamená výkonnosť v budúcnosti.